Claris collects $118M to take eye drop into pivotal testing next year

Positive

AI Analysis

Summary

Claris Bio raised $118 million in funding to advance its eye drop therapy into two pivotal trials for a blinding disease with no current pharmaceutical treatment options. The company also announced new CEO and board chair leadership.

Clinical Trial Data

Phase

Phase_3

Importance:6/10

Sentiment:

0.60

fundingpivotal_trialeye_dropunmet_medical_needrare_diseaseleadership_change

Read the original article

Published by Endpoints News on July 28, 2026 12:00 PM

Read Original